SANTHERA PHARMACEUTICALS (SCHWEIZ) AG;THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
发明人:
MEIER, THOMAS,BIELEKOVA, BIBIANA,MCFARLAND, HENRY F.
申请号：
CA2760338
公开号：
CA2760338C
申请日:
2009.12.18
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
The present invention relates to pharmaceuticals and uses thereof directed tothe curative treating or preventing ofPrimary Progressive Multiple Sclerosis. (PP-MS), by using 2, 3-dimethoxy-5-methyl-6- (10-hydroxydecyl) -1, 4-benzoquinone(Idebenone) as the active agent.
